AAAAAA

   
Results: 1-19 |
Results: 19
EXPRESSION OF P53 PREDICTS TREATMENT FAILURE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS
Authors: NAVARATNAM S WILLIAMS GJ RUBINGER M PETTIGREW NM MOWAT MRA BEGLEITER A JOHNSTON JB
Citation: S. Navaratnam et al., EXPRESSION OF P53 PREDICTS TREATMENT FAILURE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS, Leukemia & lymphoma, 29(1-2), 1998, pp. 139-144
REMISSION INDUCTION THERAPY OF UNTREATED ACUTE MYELOID-LEUKEMIA USINGA NON-CYTARABINE-CONTAINING REGIMEN OF IDARUBICIN, ETOPOSIDE, AND CARBOPLATIN
Authors: BOW EJ GALLANT G WILLIAMS GJ WOLOSCHUK D SHORE TB RUBINGER M SCHACTER BA
Citation: Ej. Bow et al., REMISSION INDUCTION THERAPY OF UNTREATED ACUTE MYELOID-LEUKEMIA USINGA NON-CYTARABINE-CONTAINING REGIMEN OF IDARUBICIN, ETOPOSIDE, AND CARBOPLATIN, Cancer, 83(7), 1998, pp. 1344-1354
WORKSHOP III - PORCINE FACTOR-VIII - CONTINUOUS-INFUSION, IMMUNE TOLERANCE INDUCTION AND PROPHYLAXIS
Authors: HAY CRM DIMICHELE D RIVARD G RUBINGER M GRIBBLE J
Citation: Crm. Hay et al., WORKSHOP III - PORCINE FACTOR-VIII - CONTINUOUS-INFUSION, IMMUNE TOLERANCE INDUCTION AND PROPHYLAXIS, Haemophilia, 3, 1997, pp. 24-30
IN-VITRO STABILITY OF PORCINE FACTOR-VIII (HYATE-C(R))
Authors: WOLOSCHUK DMM RUBINGER M ISRAELS SJ HOUSTON DS SCHWETZ N JOHNSTON JB
Citation: Dmm. Woloschuk et al., IN-VITRO STABILITY OF PORCINE FACTOR-VIII (HYATE-C(R)), Haemophilia, 3(1), 1997, pp. 21-23
RHABDOMYOLYSIS INDUCED BY EPSILON-AMINOCAPROIC ACID
Authors: SEYMOUR BD RUBINGER M
Citation: Bd. Seymour et M. Rubinger, RHABDOMYOLYSIS INDUCED BY EPSILON-AMINOCAPROIC ACID, The Annals of pharmacotherapy, 31(1), 1997, pp. 56-58
MULTIPLE-MYELOMA PRESENTING CLINICALLY AS LYMPHOMA
Authors: DAENINCK PJ WILLIAMS GJ RUBINGER M JOHNSTON JB
Citation: Pj. Daeninck et al., MULTIPLE-MYELOMA PRESENTING CLINICALLY AS LYMPHOMA, Leukemia & lymphoma, 28(1-2), 1997, pp. 195-201
CYTOTOXIC THERAPY-INDUCED D-XYLOSE MALABSORPTION AND INVASIVE INFECTION DURING REMISSION-INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA IN ADULTS
Authors: BOW EJ LOEWEN R CHEANG MS SHORE TB RUBINGER M SCHACTER B
Citation: Ej. Bow et al., CYTOTOXIC THERAPY-INDUCED D-XYLOSE MALABSORPTION AND INVASIVE INFECTION DURING REMISSION-INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA IN ADULTS, Journal of clinical oncology, 15(6), 1997, pp. 2254-2261
CONTINUOUS-INFUSION OF PORCINE FACTOR-VIII IN THE MANAGEMENT OF PATIENTS WITH FACTOR-VIII INHIBITORS
Authors: RUBINGER M HOUSTON DS SCHWETZ N WOLOSCHUK DMM ISRAELS SJ JOHNSTON JB
Citation: M. Rubinger et al., CONTINUOUS-INFUSION OF PORCINE FACTOR-VIII IN THE MANAGEMENT OF PATIENTS WITH FACTOR-VIII INHIBITORS, American journal of hematology, 56(2), 1997, pp. 112-118
THERAPY OF UNTREATED ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - REMISSION-INDUCTION USING A NON-CYTARABINE-CONTAINING REGIMEN OF MITOXANTRONE PLUS ETOPOSIDE
Authors: BOW EJ SUTHERLAND JA KILPATRICK MG WILLIAMS GJ CLINCH JJ SHORE TB RUBINGER M SCHACTER BA
Citation: Ej. Bow et al., THERAPY OF UNTREATED ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - REMISSION-INDUCTION USING A NON-CYTARABINE-CONTAINING REGIMEN OF MITOXANTRONE PLUS ETOPOSIDE, Journal of clinical oncology, 14(4), 1996, pp. 1345-1352
PANCREATITIS POST-BONE MARROW TRANSPLANTATION
Authors: SHORE T BOW E GREENBERG H PERSAD R PATTERSON D RUBINGER M SCHROEDER ML
Citation: T. Shore et al., PANCREATITIS POST-BONE MARROW TRANSPLANTATION, Bone marrow transplantation, 17(6), 1996, pp. 1181-1184
AN EPIDEMIOLOGIC REVIEW OF ANEMIA IN CANCER-CHEMOTHERAPY IN CANADA
Authors: SKILLINGS JR ROGERSMELAMED I NABHOLTZ JM SAWKA C GWADRYSRIDHAR F MOQUIN JP RUBINGER M GANGULY P BURNELL M SHUSTIK C DRYER D MCLAUGHLIN M WHITE D MERTENS W
Citation: Jr. Skillings et al., AN EPIDEMIOLOGIC REVIEW OF ANEMIA IN CANCER-CHEMOTHERAPY IN CANADA, European journal of cancer, 31A, 1995, pp. 879-879
HEMOPHILIA AND VON WILLEBRANDS DISEASE .2. MANAGEMENT
Authors: GROWE G AKABUTU J RITCHIE B POON MC WU J CARD R ALI K ISRAELS SJ RUBINGER M BLANCHETTE V TEITEL J GARVEY B WALKER I PAI MH INWOOD M DEVEBER L BRIEN W LILLICRAP DP GILES A DROUIN J LUKE KH HERST J RIVARD G STRAWCZYNSKI H JOBIN F DEMERS C LEPINE M ROBINSON S BARNARD D SCULLY MF DOLAN S RUBIN S ROSS E JARDINE L WHITMAN L INGRAM L
Citation: G. Growe et al., HEMOPHILIA AND VON WILLEBRANDS DISEASE .2. MANAGEMENT, CMAJ. Canadian Medical Association journal, 153(2), 1995, pp. 147-157
HEMOPHILIA AND VON WILLEBRANDS DISEASE .1. DIAGNOSIS, COMPREHENSIVE CARE AND ASSESSMENT
Authors: GROWE G AKABUTU J RITCHIE B POON MG WU J CARD R ALI K ISRAELS SJ RUBINGER M BLANCHETTE V TEITEL J GARVEY B WALKER I PAI M INWOOD M DEVEBER L BRIEN W LILLICRAP DP GILES A DROUIN J LUKE KH HERST J RIVARD G STRAWCZYNSKI H JOBIN F DEMERS C LEPINE M ROBINSON S BARNARD D SCULLY MF DOLAN S RUBIN S ROSS E JARDINE L WHITMAN L INGRAM L
Citation: G. Growe et al., HEMOPHILIA AND VON WILLEBRANDS DISEASE .1. DIAGNOSIS, COMPREHENSIVE CARE AND ASSESSMENT, CMAJ. Canadian Medical Association journal, 153(1), 1995, pp. 19-25
METASTATIC EXTRASKELETAL MYXOID CHONDROSARCOMA - SUCCESSFUL THERAPY WITH INTERFERON ALFA-2B
Authors: RUBINGER M PLENDERLEITH IH LERTZMAN M WORTH AJ
Citation: M. Rubinger et al., METASTATIC EXTRASKELETAL MYXOID CHONDROSARCOMA - SUCCESSFUL THERAPY WITH INTERFERON ALFA-2B, Chest, 108(1), 1995, pp. 281-282
OVER-EXPRESSION OF P53 PREDICTS LACK OF RESPONSE TO CHEMOTHERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL)
Authors: NAVARATNAM S JOHNSTON JB RUBINGER M PETTIGREW N WILLIAMS G
Citation: S. Navaratnam et al., OVER-EXPRESSION OF P53 PREDICTS LACK OF RESPONSE TO CHEMOTHERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL), Blood, 86(10), 1995, pp. 2408-2408
THE IN-VITRO STABILITY OF PORCINE FACTOR-VII (PFVIII) (HYATE-C) AND THE EFFICACY OF CONTINUOUS-INFUSION (CI) PFVIII IN THE TREATMENT OF PATIENTS WITH FVIII ANTIBODIES
Authors: RUBINGER M WOLOSCHUK DMM SCHWETZ N ISRAELS SJ HEINEMANN LC HOUSTON DS JOHNSTON JB
Citation: M. Rubinger et al., THE IN-VITRO STABILITY OF PORCINE FACTOR-VII (PFVIII) (HYATE-C) AND THE EFFICACY OF CONTINUOUS-INFUSION (CI) PFVIII IN THE TREATMENT OF PATIENTS WITH FVIII ANTIBODIES, Blood, 86(10), 1995, pp. 3532-3532
CONTINUOUS-INFUSION PORCINE FACTOR-VIII IN THE TREATMENT OF PATIENTS WITH FACTOR-VIII ANTIBODIES
Authors: RUBINGER M SCHWETZ N KHOO K ISRAELS SJ JOHNSTON JB
Citation: M. Rubinger et al., CONTINUOUS-INFUSION PORCINE FACTOR-VIII IN THE TREATMENT OF PATIENTS WITH FACTOR-VIII ANTIBODIES, Blood, 84(10), 1994, pp. 10000196-10000196
USE OF KARYOTYPIC ANALYSIS AS A PREDICTOR OF REMISSION-INDUCTION IN TREATMENT OF ACUTE MYELOID-LEUKEMIA IN THE ELDERLY
Authors: WILLIAMS GJ BOW EJ SUTHERLAND J RUBINGER M SHORE T SCHACTER B
Citation: Gj. Williams et al., USE OF KARYOTYPIC ANALYSIS AS A PREDICTOR OF REMISSION-INDUCTION IN TREATMENT OF ACUTE MYELOID-LEUKEMIA IN THE ELDERLY, Blood, 84(10), 1994, pp. 10000628-10000628
PHASE-I TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DERIVED FROM YEAST IN PATIENTS WITH BREAST-CANCER RECEIVING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND FLUOROURACIL
Authors: OREILLY SE GELMON KA ONETTO N PARENTE J RUBINGER M PAGE RA PLENDERLEITH IH
Citation: Se. Oreilly et al., PHASE-I TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DERIVED FROM YEAST IN PATIENTS WITH BREAST-CANCER RECEIVING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND FLUOROURACIL, Journal of clinical oncology, 11(12), 1993, pp. 2411-2416
Risultati: 1-19 |